Dublin, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "IV Fluid Transfer Drugs Devices and Markets" report to their offering. Intravenous drug administration is one of the most common therapeutic procedures that patients in a hospital setting are likely to receive. Yet the lack of standardization among the various components, elements and steps that a caregiver must navigate to successfully execute a drug infusion have - according to several recent studies - contributed to medication errors and risks to patient safety. IV drug administration was once provided to patients only in clinical settings. However, technology developments and a greater emphasis on cost containment over the last 30 years have prompted a shift to providing this therapy in alternate settings, including the home. IV fluid transfer drugs devices and markets is a detailed analysis of this evolving market. What You Will Learn - Analyzes and evaluates the global market for IV fluid transfer devices and assesses the probable impact of evolving regulatory, economic and demand factors - Assesses approved IV fluid transfer devices and their market position - Provides detailed descriptions of IV fluid transfer market segments and market factors - Profiles sector companies, their product development activities, supply chain partners, business strategies, and collaboration partners - Evaluates the impact of economic, technology, and regulatory factors on IV drug administration Key Topics Covered: 1. Executive Summary 2. IV Administration Market Dynamics - Evolution in Patient Care - Demand Drivers - Competitive Landscape - Factors Limiting Growth 3. IV Fluid Transfer Device Design Factors - Reducing Medication Errors - Lyophilization and Reconstitution - Provider and Patient Wellbeing 4. Device Profiles and Analysis - I.V. Containers - Fluid Transfer Devices - Reconstitution Devices 5. Market Analysis and Assessment - Autoimmune - Blood Disorders - Cardiovascular - Metabolic - Neurology - Oncology 6. Market Factors - Regulatory Factors - Managed Care Initiatives 7. Product Evolution and Wearable Infusion Devices 8. Company Profiles For more information about this report visit http://www.researchandmarkets.com/research/cn...d_transfer
CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Related Topics: Infusions and Injectables
